The purpose of this study is to evaluate the association between blood drug levels and the
corresponding scores of commonly used behavioral instruments based upon data collected
following administration of three different methylphenidate hydrochloride extended-release
drug products in children with ADHD.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Center for Psychiatry And Behavioral Medicine Inc. Food and Drug Administration (FDA)